Skip Navigation


JAC Advance Access originally published online on August 9, 2005
Journal of Antimicrobial Chemotherapy 2005 56(4):795-797; doi:10.1093/jac/dki282
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
56/4/795    most recent
dki282v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Farrell, D. J.
Right arrow Articles by Felmingham, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farrell, D. J.
Right arrow Articles by Felmingham, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Correspondence

The PROTEKT global study (year 4) demonstrates a continued lack of resistance development to telithromycin in Streptococcus pneumoniae

David J. Farrell* and David Felmingham

GR Micro Limited, 7–9 William Road, London NW1 3ER, UK

* Corresponding author. Tel: +44-20-73804469; Fax: +44-20-73887324; E-mail: d.farrell@grmicro.co.uk

Keywords: S. pneumoniae , ketolides , macrolides

The first 10% of the full text of this article appears below.

Sir,

In the early 1990s, against a background of already worrying rates of erythromycin resistance among isolates of Streptococcus pneumoniae, further sharp increases in the prevalence of macrolide resistance were observed 1 to 2 years after the introduction of the macrolides azithromycin and clarithromycin into Europe and the USA.1 This . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?